Citation Impact
Citing Papers
PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity
2018
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Recharacterizing Tumor-Infiltrating Lymphocytes by Single-Cell RNA Sequencing
2019
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
PD-1 Controls Follicular T Helper Cell Positioning and Function
2018
Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice
2023 StandoutNobel
PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity
2020
Reading the glyco-code: New approaches to studying protein–carbohydrate interactions
2022 StandoutNobel
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
2019
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
PD-L1–PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection
2022
Opportunities for Small Molecules in Cancer Immunotherapy
2020
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
2021
Pharmacological targeting of endoplasmic reticulum stress in disease
2021
Hallmarks of aging: An expanding universe
2023 Standout
Guillain-Barré syndrome
2016 Standout
Hepatocellular carcinoma
2021 Standout
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
2020 Standout
PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways
2019
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
T Cell Dysfunction in Cancer
2018
Control of Germinal Center Responses by T-Follicular Regulatory Cells
2018 StandoutNobel
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
2018
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Chronic Implant-Related Bone Infections—Can Immune Modulation be a Therapeutic Strategy?
2019
Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
2018
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
2018
Combinations of Bevacizumab With Cancer Immunotherapy
2018
PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity
2022
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
2017
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives
2017
Applications of machine learning in drug discovery and development
2019 Standout
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
2019
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
2018
CD4+ T cell help in cancer immunology and immunotherapy
2018
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment
2018
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
2019 Nobel
Immune checkpoint inhibitors: new strategies to checkmate cancer
2017
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
The double-edged sword: Harnessing PD-1 blockade in tumor and autoimmunity
2021
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
2019
Diversity, Mechanisms, and Significance of Macrophage Plasticity
2019 Standout
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions
2018
F‐domain valency determines outcome of signaling through the angiopoietin pathway
2021 StandoutNobel
Co-stimulatory function in primary germinal center responses: CD40 and B7 are required on distinct antigen-presenting cells
2017
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Control of foreign Ag‐specific Ab responses by Treg and Tfr
2020 StandoutNobel
Revisiting the PD-1 pathway
2020
T‐cell exhaustion in HIV infection
2019
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
2017
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance
2020
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy
2017
Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy
2020
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
2023 StandoutNobel
Regulation of Transmembrane Signaling by Phase Separation
2019
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Works of Heidi Ackerly Wallweber being referenced
T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
2017 Science
Activation of the IRE1 RNase through remodeling of the kinase front pocket by ATP-competitive ligands
2020